Fatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque
David R Powell, Jason P Gay, Melinda Smith, Nathaniel Wilganowski, Angela Harris, Autumn Holland, Maricela Reyes, Laura Kirkham, Laura L Kirkpatrick, Brian Zambrowicz, Gwenn Hansen, Kenneth A Platt,&am...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/c5f655ae163d4ae7842aaff60615d74f |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:c5f655ae163d4ae7842aaff60615d74f |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:c5f655ae163d4ae7842aaff60615d74f2021-12-02T08:39:15ZFatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque1178-7007https://doaj.org/article/c5f655ae163d4ae7842aaff60615d74f2016-06-01T00:00:00Zhttps://www.dovepress.com/fatty-acid-desaturase-1-knockout-mice-are-lean-with-improved-glycemic--peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007David R Powell, Jason P Gay, Melinda Smith, Nathaniel Wilganowski, Angela Harris, Autumn Holland, Maricela Reyes, Laura Kirkham, Laura L Kirkpatrick, Brian Zambrowicz, Gwenn Hansen, Kenneth A Platt, Isaac van Sligtenhorst, Zhi-Ming Ding, Urvi Desai Metabolism Research, Lexicon Pharmaceuticals, Inc., The Woodlands, TX, USA Abstract: Delta-5 desaturase (D5D) and delta-6 desaturase (D6D), encoded by fatty acid desaturase 1 (FADS1) and FADS2 genes, respectively, are enzymes in the synthetic pathways for w3, w6, and w9 polyunsaturated fatty acids (PUFAs). Although PUFAs appear to be involved in mammalian metabolic pathways, the physiologic effect of isolated D5D deficiency on these pathways is unclear. After generating >4,650 knockouts (KOs) of independent mouse genes and analyzing them in our high-throughput phenotypic screen, we found that Fads1 KO mice were among the leanest of 3,651 chow-fed KO lines analyzed for body composition and were among the most glucose tolerant of 2,489 high-fat-diet-fed KO lines analyzed by oral glucose tolerance test. In confirmatory studies, chow- or high-fat-diet-fed Fads1 KO mice were leaner than wild-type (WT) littermates; when data from multiple cohorts of adult mice were combined, body fat was 38% and 31% lower in Fads1 male and female KO mice, respectively. Fads1 KO mice also had lower glucose and insulin excursions during oral glucose tolerance tests along with lower fasting glucose, insulin, triglyceride, and total cholesterol levels. In additional studies using a vascular injury model, Fads1 KO mice had significantly decreased femoral artery intima/media ratios consistent with a decreased inflammatory response in their arterial wall. Based on this result, we bred Fads1 KO and WT mice onto an ApoE KO background and fed them a Western diet for 14 weeks; in this atherogenic environment, aortic trees of Fads1 KO mice had 40% less atheromatous plaque compared to WT littermates. Importantly, PUFA levels measured in brain and liver phospholipid fractions of Fads1 KO mice were consistent with decreased D5D activity and normal D6D activity. The beneficial metabolic phenotype demonstrated in Fads1 KO mice suggests that selective D5D inhibitors may be useful in the treatment of human obesity, diabetes, and atherosclerotic cardiovascular disease. Keywords: delta-5 desaturase, delta-6 desaturase, obesity, diabetes, atherosclerosisPowell DRGay JPSmith MWilganowski NHarris AHollAReyes MKirkham LKirkpatrick LLZambrowicz BHansen GPlatt KAvan Sligtenhorst IDing ZMDesai UDove Medical Pressarticledelta 5 desaturasedelta 6 desaturaseobesitydiabetesatherosclerosisSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol 2016, Iss Issue 1, Pp 185-199 (2016) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
delta 5 desaturase delta 6 desaturase obesity diabetes atherosclerosis Specialties of internal medicine RC581-951 |
| spellingShingle |
delta 5 desaturase delta 6 desaturase obesity diabetes atherosclerosis Specialties of internal medicine RC581-951 Powell DR Gay JP Smith M Wilganowski N Harris A Holl A Reyes M Kirkham L Kirkpatrick LL Zambrowicz B Hansen G Platt KA van Sligtenhorst I Ding ZM Desai U Fatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque |
| description |
David R Powell, Jason P Gay, Melinda Smith, Nathaniel Wilganowski, Angela Harris, Autumn Holland, Maricela Reyes, Laura Kirkham, Laura L Kirkpatrick, Brian Zambrowicz, Gwenn Hansen, Kenneth A Platt, Isaac van Sligtenhorst, Zhi-Ming Ding, Urvi Desai Metabolism Research, Lexicon Pharmaceuticals, Inc., The Woodlands, TX, USA Abstract: Delta-5 desaturase (D5D) and delta-6 desaturase (D6D), encoded by fatty acid desaturase 1 (FADS1) and FADS2 genes, respectively, are enzymes in the synthetic pathways for w3, w6, and w9 polyunsaturated fatty acids (PUFAs). Although PUFAs appear to be involved in mammalian metabolic pathways, the physiologic effect of isolated D5D deficiency on these pathways is unclear. After generating >4,650 knockouts (KOs) of independent mouse genes and analyzing them in our high-throughput phenotypic screen, we found that Fads1 KO mice were among the leanest of 3,651 chow-fed KO lines analyzed for body composition and were among the most glucose tolerant of 2,489 high-fat-diet-fed KO lines analyzed by oral glucose tolerance test. In confirmatory studies, chow- or high-fat-diet-fed Fads1 KO mice were leaner than wild-type (WT) littermates; when data from multiple cohorts of adult mice were combined, body fat was 38% and 31% lower in Fads1 male and female KO mice, respectively. Fads1 KO mice also had lower glucose and insulin excursions during oral glucose tolerance tests along with lower fasting glucose, insulin, triglyceride, and total cholesterol levels. In additional studies using a vascular injury model, Fads1 KO mice had significantly decreased femoral artery intima/media ratios consistent with a decreased inflammatory response in their arterial wall. Based on this result, we bred Fads1 KO and WT mice onto an ApoE KO background and fed them a Western diet for 14 weeks; in this atherogenic environment, aortic trees of Fads1 KO mice had 40% less atheromatous plaque compared to WT littermates. Importantly, PUFA levels measured in brain and liver phospholipid fractions of Fads1 KO mice were consistent with decreased D5D activity and normal D6D activity. The beneficial metabolic phenotype demonstrated in Fads1 KO mice suggests that selective D5D inhibitors may be useful in the treatment of human obesity, diabetes, and atherosclerotic cardiovascular disease. Keywords: delta-5 desaturase, delta-6 desaturase, obesity, diabetes, atherosclerosis |
| format |
article |
| author |
Powell DR Gay JP Smith M Wilganowski N Harris A Holl A Reyes M Kirkham L Kirkpatrick LL Zambrowicz B Hansen G Platt KA van Sligtenhorst I Ding ZM Desai U |
| author_facet |
Powell DR Gay JP Smith M Wilganowski N Harris A Holl A Reyes M Kirkham L Kirkpatrick LL Zambrowicz B Hansen G Platt KA van Sligtenhorst I Ding ZM Desai U |
| author_sort |
Powell DR |
| title |
Fatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque |
| title_short |
Fatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque |
| title_full |
Fatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque |
| title_fullStr |
Fatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque |
| title_full_unstemmed |
Fatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque |
| title_sort |
fatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque |
| publisher |
Dove Medical Press |
| publishDate |
2016 |
| url |
https://doaj.org/article/c5f655ae163d4ae7842aaff60615d74f |
| work_keys_str_mv |
AT powelldr fattyaciddesaturase1knockoutmiceareleanwithimprovedglycemiccontrolanddecreaseddevelopmentofatheromatousplaque AT gayjp fattyaciddesaturase1knockoutmiceareleanwithimprovedglycemiccontrolanddecreaseddevelopmentofatheromatousplaque AT smithm fattyaciddesaturase1knockoutmiceareleanwithimprovedglycemiccontrolanddecreaseddevelopmentofatheromatousplaque AT wilganowskin fattyaciddesaturase1knockoutmiceareleanwithimprovedglycemiccontrolanddecreaseddevelopmentofatheromatousplaque AT harrisa fattyaciddesaturase1knockoutmiceareleanwithimprovedglycemiccontrolanddecreaseddevelopmentofatheromatousplaque AT holl fattyaciddesaturase1knockoutmiceareleanwithimprovedglycemiccontrolanddecreaseddevelopmentofatheromatousplaque AT a fattyaciddesaturase1knockoutmiceareleanwithimprovedglycemiccontrolanddecreaseddevelopmentofatheromatousplaque AT reyesm fattyaciddesaturase1knockoutmiceareleanwithimprovedglycemiccontrolanddecreaseddevelopmentofatheromatousplaque AT kirkhaml fattyaciddesaturase1knockoutmiceareleanwithimprovedglycemiccontrolanddecreaseddevelopmentofatheromatousplaque AT kirkpatrickll fattyaciddesaturase1knockoutmiceareleanwithimprovedglycemiccontrolanddecreaseddevelopmentofatheromatousplaque AT zambrowiczb fattyaciddesaturase1knockoutmiceareleanwithimprovedglycemiccontrolanddecreaseddevelopmentofatheromatousplaque AT hanseng fattyaciddesaturase1knockoutmiceareleanwithimprovedglycemiccontrolanddecreaseddevelopmentofatheromatousplaque AT plattka fattyaciddesaturase1knockoutmiceareleanwithimprovedglycemiccontrolanddecreaseddevelopmentofatheromatousplaque AT vansligtenhorsti fattyaciddesaturase1knockoutmiceareleanwithimprovedglycemiccontrolanddecreaseddevelopmentofatheromatousplaque AT dingzm fattyaciddesaturase1knockoutmiceareleanwithimprovedglycemiccontrolanddecreaseddevelopmentofatheromatousplaque AT desaiu fattyaciddesaturase1knockoutmiceareleanwithimprovedglycemiccontrolanddecreaseddevelopmentofatheromatousplaque |
| _version_ |
1718398433898790912 |